CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carbon StudyJoseph P. McGuirk,Constantine S. Tam,Nicolaus Kröger,Peter A. Riedell,Hemant S. Murthy,Phoebe Joy Ho,Joseph E. Maakaron, Edmund K. Waller,Farrukh T. Awan,Paul J. Shaughnessy,Armin Ghobadi,Michael R. Bishop,Ana Alfonso-Pierola,Michael Dickinson,Praveen Ramakrishnan Geethakumari, Ainsley Ross, William Stevens,Huansheng Xu,Anna Ma,Sarah Beaussant CohenBlood（2022）引用 4|浏览21暂无评分关键词large cells lymphoma,crispr-cas,b-cellAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
